Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 267

1.

Benzylpenicillin versus flucloxacillin for penicillin susceptible Staphylococcus aureus bloodstream infections from a large retrospective cohort study.

Henderson A, Harris P, Hartel G, Paterson D, Turnidge J, Davis JS, Tong SYC.

Int J Antimicrob Agents. 2019 Jun 7. pii: S0924-8579(19)30137-2. doi: 10.1016/j.ijantimicag.2019.05.020. [Epub ahead of print]

PMID:
31181352
2.

Variation of MIC measurements: the contribution of strain and laboratory variability to measurement precision-authors' response.

Mouton JW, Meletiadis J, Voss A, Turnidge J.

J Antimicrob Chemother. 2019 Jun 1;74(6):1761-1762. doi: 10.1093/jac/dkz142. No abstract available.

PMID:
30989229
3.

Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997-2016.

Pfaller MA, Diekema DJ, Turnidge JD, Castanheira M, Jones RN.

Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S79-S94. doi: 10.1093/ofid/ofy358. eCollection 2019 Mar.

4.

Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2015.

Coombs GW, Daley DA, Lee YT, Pang S, Bell JM, Turnidge JD; Australian Group on Antimicrobial Resistance.

Commun Dis Intell (2018). 2018;42. pii: S2209-6051(18)00016-7. Epub 2018 Dec 17.

5.

Australian Group on Antimicrobial Resistance (AGAR) Australian Enterococcal Sepsis Outcome Programme(AESOP) Annual Report 2015.

Coombs GW, Daley DA, Lee YT, Pang S, Bell JM, Turnidge JD; Australian Group on Antimicrobial Resistance.

Commun Dis Intell (2018). 2018;42. pii: S2209-6051(18)00015-5. Epub 2018 Dec 17.

6.

Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods.

Espinel-Ingroff A, Turnidge J, Alastruey-Izquierdo A, Botterel F, Canton E, Castro C, Chen YC, Chen Y, Chryssanthou E, Dannaoui E, Garcia-Effron G, Gonzalez GM, Govender NP, Guinea J, Kidd S, Lackner M, Lass-Flörl C, Linares-Sicilia MJ, López-Soria L, Magobo R, Pelaez T, Quindós G, Rodriguez-Iglesia MA, Ruiz MA, Sánchez-Reus F, Sanguinetti M, Shields R, Szweda P, Tortorano A, Wengenack NL, Bramati S, Cavanna C, DeLuca C, Gelmi M, Grancini A, Lombardi G, Meletiadis J, Negri CE, Passera M, Peman J, Prigitano A, Sala E, Tejada M.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01651-18. doi: 10.1128/AAC.01651-18. Print 2019 Jan.

7.

Variation of MIC measurements: the contribution of strain and laboratory variability to measurement precision.

Mouton JW, Meletiadis J, Voss A, Turnidge J.

J Antimicrob Chemother. 2018 Sep 1;73(9):2374-2379. doi: 10.1093/jac/dky232.

PMID:
30137390
8.

MIC-based dose adjustment: facts and fables-authors' response.

Mouton JW, Muller AE, Canton R, G Giske C, Kahlmeter G, Turnidge J.

J Antimicrob Chemother. 2018 Sep 1;73(9):2585-2586. doi: 10.1093/jac/dky195. No abstract available.

PMID:
30137389
9.

A plea from EUCAST for standardization of disc susceptibility testing antimicrobial codes.

Turnidge J, Lina G, Giske C; European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee.

Clin Microbiol Infect. 2018 Dec;24(12):1345. doi: 10.1016/j.cmi.2018.08.007. Epub 2018 Aug 11. No abstract available.

PMID:
30107280
10.

Morbidity from in-hospital complications is greater than treatment failure in patients with Staphylococcus aureus bacteraemia.

Holmes NE, Robinson JO, van Hal SJ, Munckhof WJ, Athan E, Korman TM, Cheng AC, Turnidge JD, Johnson PDR, Howden BP; VANESSA study group, on behalf of the Australasian Society for Infectious Diseases (ASID) Clinical Research Network (CRN).

BMC Infect Dis. 2018 Mar 5;18(1):107. doi: 10.1186/s12879-018-3011-2.

11.

A large retrospective cohort study of cefazolin compared with flucloxacillin for methicillin-susceptible Staphylococcus aureus bacteraemia.

Davis JS, Turnidge J, Tong S.

Int J Antimicrob Agents. 2018 Aug;52(2):297-300. doi: 10.1016/j.ijantimicag.2018.02.013. Epub 2018 Feb 28.

PMID:
29499317
12.

Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of cyp51A Mutations on Estimation of Epidemiological Cutoff Values.

Espinel-Ingroff A, Turnidge J, Alastruey-Izquierdo A, Dannaoui E, Garcia-Effron G, Guinea J, Kidd S, Pelaez T, Sanguinetti M, Meletiadis J, Botterel F, Bustamante B, Chen YC, Chakrabarti A, Chowdhary A, Chryssanthou E, Córdoba S, Gonzalez GM, Guarro J, Johnson EM, Kus JV, Lass-Flörl C, Linares-Sicilia MJ, Martín-Mazuelos E, Negri CE, Pfaller MA, Tortorano AM.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e01916-17. doi: 10.1128/AAC.01916-17. Print 2018 Apr.

13.

Relative performance of antimicrobial susceptibility assays on clinical Escherichia coli isolates from animals.

Badger S, Abraham S, Saputra S, Trott DJ, Turnidge J, Mitchell T, Caraguel CGB, Jordan D.

Vet Microbiol. 2018 Feb;214:56-64. doi: 10.1016/j.vetmic.2017.12.008. Epub 2017 Dec 12.

PMID:
29408033
14.

Elucidating the Pharmacokinetics/Pharmacodynamics of Aerosolized Colistin against Multidrug-Resistant Acinetobacter baumannii and Klebsiella pneumoniae in a Mouse Lung Infection Model.

Lin YW, Zhou QT, Han ML, Chen K, Onufrak NJ, Wang J, Turnidge JD, Howden BP, Forrest A, Chan HK, Li J.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01790-17. doi: 10.1128/AAC.01790-17. Print 2018 Feb.

15.

MIC-based dose adjustment: facts and fables.

Mouton JW, Muller AE, Canton R, Giske CG, Kahlmeter G, Turnidge J.

J Antimicrob Chemother. 2018 Mar 1;73(3):564-568. doi: 10.1093/jac/dkx427.

PMID:
29216348
16.

Proposed method for estimating clinical cut-off (COCL) values: An attempt to address challenges encountered when setting clinical breakpoints for veterinary antimicrobial agents.

Turnidge JD, Martinez MN.

Vet J. 2017 Oct;228:33-37. doi: 10.1016/j.tvjl.2017.10.004. Epub 2017 Oct 16. No abstract available.

PMID:
29153105
17.

Antimicrobial resistance in clinical Escherichia coli isolated from companion animals in Australia.

Saputra S, Jordan D, Mitchell T, Wong HS, Abraham RJ, Kidsley A, Turnidge J, Trott DJ, Abraham S.

Vet Microbiol. 2017 Nov;211:43-50. doi: 10.1016/j.vetmic.2017.09.014. Epub 2017 Sep 21.

PMID:
29102120
18.

Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent.

Ogunniyi AD, Khazandi M, Stevens AJ, Sims SK, Page SW, Garg S, Venter H, Powell A, White K, Petrovski KR, Laven-Law G, Tótoli EG, Salgado HR, Pi H, Coombs GW, Shinabarger DL, Turnidge JD, Paton JC, McCluskey A, Trott DJ.

PLoS One. 2017 Sep 5;12(9):e0183457. doi: 10.1371/journal.pone.0183457. eCollection 2017.

19.

Multicenter, International Study of MIC/MEC Distributions for Definition of Epidemiological Cutoff Values for Sporothrix Species Identified by Molecular Methods.

Espinel-Ingroff A, Abreu DPB, Almeida-Paes R, Brilhante RSN, Chakrabarti A, Chowdhary A, Hagen F, Córdoba S, Gonzalez GM, Govender NP, Guarro J, Johnson EM, Kidd SE, Pereira SA, Rodrigues AM, Rozental S, Szeszs MW, Ballesté Alaniz R, Bonifaz A, Bonfietti LX, Borba-Santos LP, Capilla J, Colombo AL, Dolande M, Isla MG, Melhem MSC, Mesa-Arango AC, Oliveira MME, Panizo MM, Pires de Camargo Z, Zancope-Oliveira RM, Meis JF, Turnidge J.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e01057-17. doi: 10.1128/AAC.01057-17. Print 2017 Oct.

20.

Assessing the public acceptability of proposed policy interventions to reduce the misuse of antibiotics in Australia: A report on two community juries.

Degeling C, Johnson J, Iredell J, Nguyen KA, Norris JM, Turnidge JD, Dawson A, Carter SM, Gilbert GL.

Health Expect. 2018 Feb;21(1):90-99. doi: 10.1111/hex.12589. Epub 2017 Jun 30.

21.
22.

Antimicrobial use and resistance in Australia.

Turnidge J.

Aust Prescr. 2017 Feb;40(1):2-3. doi: 10.18773/austprescr.2017.007. Epub 2017 Feb 1. No abstract available.

23.

Antimicrobial use Guidelines for Treatment of Respiratory Tract Disease in Dogs and Cats: Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases.

Lappin MR, Blondeau J, Boothe D, Breitschwerdt EB, Guardabassi L, Lloyd DH, Papich MG, Rankin SC, Sykes JE, Turnidge J, Weese JS.

J Vet Intern Med. 2017 Mar;31(2):279-294. doi: 10.1111/jvim.14627. Epub 2017 Feb 10.

24.

Determination of disk diffusion susceptibility testing interpretive criteria using model-based analysis: development and implementation.

DePalma G, Turnidge J, Craig BA.

Diagn Microbiol Infect Dis. 2017 Feb;87(2):143-149. doi: 10.1016/j.diagmicrobio.2016.03.004. Epub 2016 Mar 2.

PMID:
27856043
25.

Antimicrobial use in Australian hospitals: how much and how appropriate?

Turnidge JD, Thursky K, Chen CS, McNeil VR, Wilkinson IJ.

Med J Aust. 2016 Nov 21;205(10):S16-S20.

PMID:
27852197
26.

First detection of extended-spectrum cephalosporin- and fluoroquinolone-resistant Escherichia coli in Australian food-producing animals.

Abraham S, Jordan D, Wong HS, Johnson JR, Toleman MA, Wakeham DL, Gordon DM, Turnidge JD, Mollinger JL, Gibson JS, Trott DJ.

J Glob Antimicrob Resist. 2015 Dec;3(4):273-277. doi: 10.1016/j.jgar.2015.08.002. Epub 2015 Sep 28.

PMID:
27842872
27.

Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition.

Harris PNA, McNamara JF, Lye DC, Davis JS, Bernard L, Cheng AC, Doi Y, Fowler VG Jr, Kaye KS, Leibovici L, Lipman J, Llewelyn MJ, Munoz-Price S, Paul M, Peleg AY, Rodríguez-Baño J, Rogers BA, Seifert H, Thamlikitkul V, Thwaites G, Tong SYC, Turnidge J, Utili R, Webb SAR, Paterson DL.

Clin Microbiol Infect. 2017 Aug;23(8):533-541. doi: 10.1016/j.cmi.2016.10.023. Epub 2016 Nov 1. Review.

28.

Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method.

Espinel-Ingroff A, Arendrup M, Cantón E, Cordoba S, Dannaoui E, García-Rodríguez J, Gonzalez GM, Govender NP, Martin-Mazuelos E, Lackner M, Lass-Flörl C, Linares Sicilia MJ, Rodriguez-Iglesias MA, Pelaez T, Shields RK, Garcia-Effron G, Guinea J, Sanguinetti M, Turnidge J.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e01792-16. doi: 10.1128/AAC.01792-16. Print 2017 Jan.

29.

Phylogenetic diversity, antimicrobial susceptibility and virulence characteristics of phylogroup F Escherichia coli in Australia.

Vangchhia B, Abraham S, Bell JM, Collignon P, Gibson JS, Ingram PR, Johnson JR, Kennedy K, Trott DJ, Turnidge JD, Gordon DM.

Microbiology. 2016 Nov;162(11):1904-1912. doi: 10.1099/mic.0.000367. Epub 2016 Sep 22.

PMID:
27666313
30.

Epidemiology and Mortality of Staphylococcus aureus Bacteremia in Australian and New Zealand Children.

McMullan BJ, Bowen A, Blyth CC, Van Hal S, Korman TM, Buttery J, Voss L, Roberts S, Cooper C, Tong SY, Turnidge J.

JAMA Pediatr. 2016 Oct 1;170(10):979-986. doi: 10.1001/jamapediatrics.2016.1477.

PMID:
27533601
31.

Australian Group on Antimicrobial Resistance Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2014.

Coombs GW, Daley DA, Thin Lee Y, Pearson JC, Robinson JO, Nimmo GR, Collignon P, Howden BP, Bell JM, Turnidge JD; Australian Group on Antimicrobial Resistance.

Commun Dis Intell Q Rep. 2016 Jun 30;40(2):E244-54.

32.

Australian Group on Antimicrobial Resistance Australian Enterococcal Sepsis Outcome Programme annual report, 2014.

Coombs GW, Daley DA, Thin Lee Y, Pang S, Pearson JC, Robinson JO, Johnson PD, Kotsanas D, Bell JM, Turnidge JD; Australian Group on Antimicrobial Resistance.

Commun Dis Intell Q Rep. 2016 Jun 30;40(2):E236-43.

33.

Australian Group on Antimicrobial Resistance Australian Enterobacteriaceae Sepsis Outcome Programme annual report, 2014.

Bell JM, Turnidge JD, Coombs GW, Daley DA, Gottlieb T, Robson J, George N.

Commun Dis Intell Q Rep. 2016 Jun 30;40(2):E229-35.

34.

The role of epidemiological cutoff values (ECVs/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds.

Espinel-Ingroff A, Turnidge J.

Rev Iberoam Micol. 2016 Apr-Jun;33(2):63-75. doi: 10.1016/j.riam.2016.04.001. Epub 2016 Jun 11. Review.

PMID:
27296911
35.

Resistance sans frontières: containing antimicrobial resistance nationally and globally.

Turnidge J, Baggoley C, Schipp M, Martin R.

Med J Aust. 2016 Apr 4;204(6):207-8. No abstract available.

PMID:
27031386
36.

SaMpling Antibiotics in Renal Replacement Therapy (SMARRT): an observational pharmacokinetic study in critically ill patients.

Roberts JA, Choi GY, Joynt GM, Paul SK, Deans R, Peake S, Cole L, Stephens D, Bellomo R, Turnidge J, Wallis SC, Roberts MS, Roberts DM, Lassig-Smith M, Starr T, Lipman J.

BMC Infect Dis. 2016 Mar 1;16:103. doi: 10.1186/s12879-016-1421-6.

37.

Predictability of Phenotype in Relation to Common β-Lactam Resistance Mechanisms in Escherichia coli and Klebsiella pneumoniae.

Agyekum A, Fajardo-Lubián A, Ai X, Ginn AN, Zong Z, Guo X, Turnidge J, Partridge SR, Iredell JR.

J Clin Microbiol. 2016 May;54(5):1243-50. doi: 10.1128/JCM.02153-15. Epub 2016 Feb 24.

38.

International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method.

Espinel-Ingroff A, Colombo AL, Cordoba S, Dufresne PJ, Fuller J, Ghannoum M, Gonzalez GM, Guarro J, Kidd SE, Meis JF, Melhem TM, Pelaez T, Pfaller MA, Szeszs MW, Takahaschi JP, Tortorano AM, Wiederhold NP, Turnidge J.

Antimicrob Agents Chemother. 2015 Dec 7;60(2):1079-84. doi: 10.1128/AAC.02456-15. Print 2016 Feb.

39.

Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?

Nation RL, Garonzik SM, Li J, Thamlikitkul V, Giamarellos-Bourboulis EJ, Paterson DL, Turnidge JD, Forrest A, Silveira FP.

Clin Infect Dis. 2016 Mar 1;62(5):552-558. doi: 10.1093/cid/civ964. Epub 2015 Nov 25.

40.

New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection.

Cheah SE, Wang J, Nguyen VT, Turnidge JD, Li J, Nation RL.

J Antimicrob Chemother. 2015 Dec;70(12):3291-7. doi: 10.1093/jac/dkv267. Epub 2015 Aug 27.

PMID:
26318190
41.

Multicenter study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin, and micafungin using the Sensititre YeastOne colorimetric method.

Espinel-Ingroff A, Alvarez-Fernandez M, Cantón E, Carver PL, Chen SC, Eschenauer G, Getsinger DL, Gonzalez GM, Govender NP, Grancini A, Hanson KE, Kidd SE, Klinker K, Kubin CJ, Kus JV, Lockhart SR, Meletiadis J, Morris AJ, Pelaez T, Quindós G, Rodriguez-Iglesias M, Sánchez-Reus F, Shoham S, Wengenack NL, Borrell Solé N, Echeverria J, Esperalba J, Gómez-G de la Pedrosa E, García García I, Linares MJ, Marco F, Merino P, Pemán J, Pérez Del Molino L, Roselló Mayans E, Rubio Calvo C, Ruiz Pérez de Pipaon M, Yagüe G, Garcia-Effron G, Guinea J, Perlin DS, Sanguinetti M, Shields R, Turnidge J.

Antimicrob Agents Chemother. 2015 Nov;59(11):6725-32. doi: 10.1128/AAC.01250-15. Epub 2015 Aug 17.

42.

Reviving old antibiotics.

Theuretzbacher U, Van Bambeke F, Cantón R, Giske CG, Mouton JW, Nation RL, Paul M, Turnidge JD, Kahlmeter G.

J Antimicrob Chemother. 2015 Aug;70(8):2177-81. doi: 10.1093/jac/dkv157. Epub 2015 Jun 10. Review.

PMID:
26063727
43.

Improved Synthesis of Biotinol-5'-AMP: Implications for Antibacterial Discovery.

Tieu W, Polyak SW, Paparella AS, Yap MY, Soares da Costa TP, Ng B, Wang G, Lumb R, Bell JM, Turnidge JD, Wilce MC, Booker GW, Abell AD.

ACS Med Chem Lett. 2014 Dec 11;6(2):216-20. doi: 10.1021/ml500475n. eCollection 2015 Feb 12.

44.

Use of in vitro vancomycin testing results to predict susceptibility to oritavancin, a new long-acting lipoglycopeptide.

Jones RN, Turnidge JD, Moeck G, Arhin FF, Mendes RE.

Antimicrob Agents Chemother. 2015 Apr;59(4):2405-9. doi: 10.1128/AAC.05098-14. Epub 2015 Feb 9.

45.

Vancomycin vintage: my favourite DRESS.

Korman TM, Turnidge JD, Grayson ML.

Intern Med J. 2015 Feb;45(2):233-4. doi: 10.1111/imj.12660. No abstract available.

PMID:
25650542
46.

Enterobacteriaceae Sepsis Outcome Programme annual report, 2013.

Turnidge JD, Gottlieb T, Mitchell DH, Coombs GW, Daly DA, Bell JM; Australian Group on Antimicrobial Resistance.

Commun Dis Intell Q Rep. 2014 Dec 31;38(4):E327-33.

47.

Australian Enterococcal Sepsis Outcome Programme annual report, 2013.

Coombs GW, Pearson JC, Daly DA, Le TT, Robinson JO, Gottlieb T, Howden BP, Johnson PD, Bennett CM, Stinear TP, Turnidge JD; Australian Group on Antimicrobial Resistance.

Commun Dis Intell Q Rep. 2014 Dec 31;38(4):E320-6.

48.

Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013.

Coombs GW, Nimmo GR, Daly DA, Le TT, Pearson JC, Tan HL, Robinson JO, Collignon PJ, McLaws ML, Turnidge JD; Australian Group on Antimicrobial Resistance.

Commun Dis Intell Q Rep. 2014 Dec 31;38(4):E309-19.

49.

Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales.

Espinel-Ingroff A, Chakrabarti A, Chowdhary A, Cordoba S, Dannaoui E, Dufresne P, Fothergill A, Ghannoum M, Gonzalez GM, Guarro J, Kidd S, Lass-Flörl C, Meis JF, Pelaez T, Tortorano AM, Turnidge J.

Antimicrob Agents Chemother. 2015 Mar;59(3):1745-50. doi: 10.1128/AAC.04435-14. Epub 2015 Jan 12.

50.

Antimicrobial susceptibility testing for bovine respiratory disease: getting more from diagnostic results.

Lubbers BV, Turnidge J.

Vet J. 2015 Feb;203(2):149-54. doi: 10.1016/j.tvjl.2014.12.009. Epub 2014 Dec 18. Review.

PMID:
25582794

Supplemental Content

Loading ...
Support Center